Cargando…
Identification of the Additional Mitochondrial Liabilities of 2-Hydroxyflutamide When Compared With its Parent Compound, Flutamide in HepG2 Cells
The androgen receptor antagonist, flutamide, is strongly associated with idiosyncratic drug-induced liver injury (DILI). Following administration, flutamide undergoes extensive first-pass metabolism to its primary metabolite, 2-hydroxyflutamide. Flutamide is a known mitochondrial toxicant; however t...
Autores principales: | Ball, Amy L., Kamalian, Laleh, Alfirevic, Ana, Lyon, Jonathan J., Chadwick, Amy E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036617/ https://www.ncbi.nlm.nih.gov/pubmed/27413113 http://dx.doi.org/10.1093/toxsci/kfw126 |
Ejemplares similares
-
The generation of HepG2 transmitochondrial cybrids to reveal the role of mitochondrial genotype in idiosyncratic drug-induced liver injury
por: Ball, Amy Louise, et al.
Publicado: (2023) -
Next Generation Risk Assessment of the Anti-Androgen Flutamide Including the Contribution of Its Active Metabolite Hydroxyflutamide
por: van Tongeren, Tessa C.A., et al.
Publicado: (2022) -
Metabolic manipulators: a well founded strategy to combat mitochondrial dysfunction
por: Koene, Saskia, et al.
Publicado: (2010) -
Biochemical diagnosis of mitochondrial disorders
por: Rodenburg, Richard J. T.
Publicado: (2010) -
COA7 (C1orf163/RESA1) mutations associated with mitochondrial leukoencephalopathy and cytochrome c oxidase deficiency
por: Martinez Lyons, Anabel, et al.
Publicado: (2016)